<?xml version="1.0" encoding="UTF-8"?>

<Library xmlns="http://hl7.org/fhir">
  <id value="HIVIND45Logic"/>
  <meta>
    <profile value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"/>
    <profile value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"/>
    <profile value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"/>
    <profile value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Library HIVIND45Logic</b></p><a name="HIVIND45Logic"> </a><a name="hcHIVIND45Logic"> </a><a name="HIVIND45Logic-en-US"> </a><h2>Contents</h2><p><code>text/cql</code></p><pre><code class="language-sql">/**
 * Library: HIV.IND.45 Logic
 * Ref No: TBH.2
 * Short Name: TPT completion
 *
 * Definition: Number and % of people living with HIV on ART who completed a course of TB preventive treatment among those who initiated TPT
 *
 * Numerator: Number of ART patients who completed a course of TPT during the reporting period
 * Numerator Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND &quot;On ART&quot;=True AND &quot;TB preventive treatment (TPT) start date&quot; in the previous period AND &quot;TB preventive treatment (TPT) status&quot;='Completed'
 * Numerator Exclusions: 
 *
 * Denominator: Number of ART patients who initiated any course of TPT during the previous reporting period
 * Denominator Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND &quot;On ART&quot;=True AND &quot;TB preventive treatment (TPT) start date&quot; in the prior reporting period
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (female, male, other*) 
 *  • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50+ years)** 
 *  • Type of TPT regimen 
 *  • ART initiation (&lt;12 months on ART, 12+ months on ART) 
 *  • Cities and other administrative regions of epidemiologic importance
 *
 * Disaggregation Elements: Gender | Age | TPT regimen type | ART start date (&lt;12 months on ART, ≥12 months on ART)
 *
 * Numerator and Denominator Elements:
 * HIV status 
 *  On ART 
 *  TB preventive treatment (TPT) start date 
 *  TB preventive treatment (TPT) status
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.
 * HIV.B.DE116: HIV-positive | Client is HIV-positive
 * HIV.B.DE117: HIV-negative | Client is HIV-negative
 * HIV.B.DE118: Unknown | Client has unknown HIV status
 * HIV.D.DE38: On ART | Client is currently taking ART
 * HIV.D.DE39: ART start date | The date on which the client started or restarted ART
 * HIV.D.DE954: TB preventive treatment (TPT) start date | The date on which the client began taking TPT
 * HIV.D.DE1028: TPT regimen type | Type of TPT regimen the client is currently on
 * HIV.D.DE1029: 3HP | The client's current TPT regimen is 3HP
 * HIV.D.DE1030: 1HP | The client's current TPT regimen is 1HP
 * HIV.D.DE1031: 6H | The client's current TPT regimen is 6H
 * HIV.D.DE1032: Six months of levofloxacin daily | The client's current TPT regimen is six months of levofloxacin daily
 * HIV.D.DE1033: Other TB preventive treatment (TPT) regimen | The client's current TPT regimen is another regimen than those listed above
 * HIV.D.DE1034: TB preventive treatment (TPT) status | Indicates the current status of TB preventive treatment (TPT)
 * HIV.D.DE1035: Not started | The client did not start the TB preventive treatment (TPT)
 * HIV.D.DE1036: On TPT | The client started the TB preventive treatment (TPT) and is currently taking the medication, without treatment interruptions
 * HIV.D.DE1037: On TPT with interruptions | The client started the TB preventive treatment (TPT) and is currently taking the medication, with treatment interruptions
 * HIV.D.DE1038: On hold | The health care worker has temporarily stopped the TB preventive treatment (TPT), but TPT is expected to continue again later. May also be called &quot;suspended&quot;.
 * HIV.D.DE1039: Completed | TB preventive treatment (TPT) was completed
 * HIV.H.DE47: On ART | Client is currently taking ART 
 * HIV.SRV.DE6: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 *
 * Additional Context
 * - what it measures: This indicator measures the effectiveness of scaled-up TPT programmes by assessing the proportion of patients who completed the recommended course of TPT.
 * - rationale: • Many countries have made progress in initiating eligible people living with HIV on TPT. However, rates of TPT completion remain poor or unknown. | • Assessment of TPT completion is a critical element of the TB/HIV cascade of services.
 * - method: For the numerator and denominator: Programme records (for example, ART registers) |  | Defining &quot;previous reporting period&quot;: For example, for annual reporting of January to December 2021, the previous reporting period is January to December 2020 (except for programmes with 1HP-exclusive national guidelines and implementation, in which case they may use January to December 2021). For quarterly or semi-annual reporting to the national level, the previous reporting period will depend on the TPT regimen and duration defined by national guidelines. |  | Note: For programmes using continuous isoniazid preventive therapy (IPT), TPT completion is defined as six months of treatment. | 
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND45Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include FHIRCommon called FC
include WHOCommon called WCom

// Indicator Definition
parameter &quot;Measurement Period&quot; Interval&lt;Date&gt; default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define &quot;Initial Population&quot;:
  true

/**
 * Numerator
 * 
 * Definition: Number of ART patients who completed a course of TPT during the reporting period
 * Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND &quot;On ART&quot;=True AND &quot;TB preventive treatment (TPT) start date&quot; in the previous period AND &quot;TB preventive treatment (TPT) status&quot;='Completed'
 */

define &quot;Numerator&quot;:
  true


/**
 * Denominator
 *
 * Definition: Number of ART patients who initiated any course of TPT during the previous reporting period
 * Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND &quot;On ART&quot;=True AND &quot;TB preventive treatment (TPT) start date&quot; in the prior reporting period
 */

define &quot;Denominator&quot;:
  true
    

/* end Populations */

</code></pre><p><code>No Content</code> (<code>application/elm+xml</code>)</p></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <url value="http://smart.who.int/HIV/Library/HIVIND45Logic"/>
  <version value="0.2.0"/>
  <name value="HIVIND45Logic"/>
  <title value="HIV.IND.45 Logic"/>
  <status value="draft"/>
  <experimental value="true"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/library-type"/>
      <code value="logic-library"/>
    </coding>
  </type>
  <date value="2024-08-06T17:04:54+00:00"/>
  <publisher value="WHO"/>
  <contact>
    <name value="WHO"/>
    <telecom>
      <system value="url"/>
      <value value="http://who.int"/>
    </telecom>
  </contact>
  <description value="Number and % of people living with HIV on ART who completed a course of TB preventive treatment among those who initiated TPT"/>
  <content>
    <contentType value="text/cql"/>
    <data value="/**
 * Library: HIV.IND.45 Logic
 * Ref No: TBH.2
 * Short Name: TPT completion
 *
 * Definition: Number and % of people living with HIV on ART who completed a course of TB preventive treatment among those who initiated TPT
 *
 * Numerator: Number of ART patients who completed a course of TPT during the reporting period
 * Numerator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True AND "TB preventive treatment (TPT) start date" in the previous period AND "TB preventive treatment (TPT) status"='Completed'
 * Numerator Exclusions: 
 *
 * Denominator: Number of ART patients who initiated any course of TPT during the previous reporting period
 * Denominator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True AND "TB preventive treatment (TPT) start date" in the prior reporting period
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (female, male, other*) 
 *  • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50+ years)** 
 *  • Type of TPT regimen 
 *  • ART initiation (<12 months on ART, 12+ months on ART) 
 *  • Cities and other administrative regions of epidemiologic importance
 *
 * Disaggregation Elements: Gender | Age | TPT regimen type | ART start date (<12 months on ART, ≥12 months on ART)
 *
 * Numerator and Denominator Elements:
 * HIV status 
 *  On ART 
 *  TB preventive treatment (TPT) start date 
 *  TB preventive treatment (TPT) status
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.
 * HIV.B.DE116: HIV-positive | Client is HIV-positive
 * HIV.B.DE117: HIV-negative | Client is HIV-negative
 * HIV.B.DE118: Unknown | Client has unknown HIV status
 * HIV.D.DE38: On ART | Client is currently taking ART
 * HIV.D.DE39: ART start date | The date on which the client started or restarted ART
 * HIV.D.DE954: TB preventive treatment (TPT) start date | The date on which the client began taking TPT
 * HIV.D.DE1028: TPT regimen type | Type of TPT regimen the client is currently on
 * HIV.D.DE1029: 3HP | The client's current TPT regimen is 3HP
 * HIV.D.DE1030: 1HP | The client's current TPT regimen is 1HP
 * HIV.D.DE1031: 6H | The client's current TPT regimen is 6H
 * HIV.D.DE1032: Six months of levofloxacin daily | The client's current TPT regimen is six months of levofloxacin daily
 * HIV.D.DE1033: Other TB preventive treatment (TPT) regimen | The client's current TPT regimen is another regimen than those listed above
 * HIV.D.DE1034: TB preventive treatment (TPT) status | Indicates the current status of TB preventive treatment (TPT)
 * HIV.D.DE1035: Not started | The client did not start the TB preventive treatment (TPT)
 * HIV.D.DE1036: On TPT | The client started the TB preventive treatment (TPT) and is currently taking the medication, without treatment interruptions
 * HIV.D.DE1037: On TPT with interruptions | The client started the TB preventive treatment (TPT) and is currently taking the medication, with treatment interruptions
 * HIV.D.DE1038: On hold | The health care worker has temporarily stopped the TB preventive treatment (TPT), but TPT is expected to continue again later. May also be called "suspended".
 * HIV.D.DE1039: Completed | TB preventive treatment (TPT) was completed
 * HIV.H.DE47: On ART | Client is currently taking ART 
 * HIV.SRV.DE6: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 *
 * Additional Context
 * - what it measures: This indicator measures the effectiveness of scaled-up TPT programmes by assessing the proportion of patients who completed the recommended course of TPT.
 * - rationale: • Many countries have made progress in initiating eligible people living with HIV on TPT. However, rates of TPT completion remain poor or unknown. | • Assessment of TPT completion is a critical element of the TB/HIV cascade of services.
 * - method: For the numerator and denominator: Programme records (for example, ART registers) |  | Defining "previous reporting period": For example, for annual reporting of January to December 2021, the previous reporting period is January to December 2020 (except for programmes with 1HP-exclusive national guidelines and implementation, in which case they may use January to December 2021). For quarterly or semi-annual reporting to the national level, the previous reporting period will depend on the TPT regimen and duration defined by national guidelines. |  | Note: For programmes using continuous isoniazid preventive therapy (IPT), TPT completion is defined as six months of treatment. | 
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND45Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include FHIRCommon called FC
include WHOCommon called WCom

// Indicator Definition
parameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define "Initial Population":
  true

/**
 * Numerator
 * 
 * Definition: Number of ART patients who completed a course of TPT during the reporting period
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True AND "TB preventive treatment (TPT) start date" in the previous period AND "TB preventive treatment (TPT) status"='Completed'
 */

define "Numerator":
  true


/**
 * Denominator
 *
 * Definition: Number of ART patients who initiated any course of TPT during the previous reporting period
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True AND "TB preventive treatment (TPT) start date" in the prior reporting period
 */

define "Denominator":
  true
    

/* end Populations */

"/>
  </content>
  <content>
    <contentType value="application/elm+xml"/>
  </content>
</Library>